X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

Yuvraj_pawp by Yuvraj_pawp
29th May 2014
in Research & Development

The Orphan Drugs Market is set to Rise as a Result of Pharma Companies
now Looking to Orphan Drugs as an Essential Revenue Stream in 2014

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments. 

Based on this information SMi Group is proud to announce it will be hosting the 3rd conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Novabiotics, Pfizer, AstraZeneca, GMP Orphan SAS, Genethon and M&C Saatchi and many more to discuss the latest developments in the market. 

Benefits of Attending:

  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Hear important insights from Ian Hudson, CEO, MHRA on the Early Access to Medicines Initiative and adaptive licensing.
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Focus on enhancing development pathways, with the growth of the commercial pipeline for orphan drugs and rare diseases.
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Assess tools for consideration to gain early market access and enhance patient recruitment. 
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Interactive round table discussion led by Dominic Nutt, Director of Communications, The Saatchi Cancer Initiative,M&C Saatchi on creating a culture of innovation in the field of orphan drugs and rare diseases.

Key Speakers:


  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Dr Gunter Harms, Market Access & Public Affairs Directore, Shire 
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Bertram Haussle, Chaiman of the Board of Management, IGES Institut 
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Josie Godfrey, Associate Director-Highly Specialised Technologies, NICE 
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Chris Hart, Information Practice Leader, AstraZeneca 
  • http://www.worldpharmatoday.com/templates/ja_teline_iii/images/bullet.gif) 15px 6px no-repeat;”>Anthony Hall, Co-Founder, Findacure Foundation 

For more information please visit http://www.smi-online.co.uk/2014orphandrugs66.asp

If you would like to attend this conference as a delegate please contact John Collins on +44 (0) 207 827 6734 or e-mailjcollins@smi-online.co.uk

If you are interested in sponsoring this event contact Alia Malick on +44(0)20 7827 6168 or email amalick@smi-online.co.uk

If you would like to become a media partner contact Sarah Watson on +44 (0)20 7827 6134 or email swatson@smi-online.co.uk

 

Previous Post

VA’S CONVOLUTED PATIENT SCHEDULING STARTS WITH A ‘HELPLINE’ CALL

Next Post

Chemistry: Provence Technologies acquires Synprosis

Related Posts

News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
Report Indicates UK £62bn Behind In Global R&D Investment
News

Report Indicates UK £62bn Behind In Global R&D Investment

3rd November 2022
News

Once More, M&As In Biotechechnology Industry Are Thriving

2nd November 2022
DNA
News

Ancient Viral DNA Guards Against Infections In Human Genome

31st October 2022
News

Omicron Subvariants Withstand Essential Antibody Treatments

31st October 2022
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Research And Development In UK Falls Behind Other Nations

28th October 2022
Next Post

Chemistry: Provence Technologies acquires Synprosis

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In